Results from the Phase III ZENITH trial show that Winrevair lowered the risk of all-cause death, lung transplantation, and ...

Approval was based on results from the Phase III ALIGN study, which demonstrated a significant reduction in proteinuria at 36 ...

Marcel Botha, CEO of 10XBeta, identifies the most significant technological innovations in medical device manufacturing that ...

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...

BIIB080 marks the first antisense oligonucleotide targeting tau to enter clinical development for the treatment of Alzheimer ...

LillyDirect will help provide services to millions of patients who have yet to be formally diagnosed with the disease.

Matthew Yelovich, partner at Cleary Gottlieb, discusses the appeals of Elizabeth Holmes and Ramesh "Sunny" Balwani and the ...

The line-up consists of supplements to meet the health needs to patients taking GLP-1 medications for weight loss.

Kanvas Biosciences’ new research suggests that the company’s HiPR-Map Platform is capable of outperforming traditional ...

Marcel Botha, CEO of 10XBeta, discusses lessons from The Spiro Wave project that can be applied in creating more agile and ...